We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+10.13%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.22B
AUM Growth
+$102M
Cap. Flow
-$1.03M
Cap. Flow %
-0.08%
Top 10 Hldgs %
38.19%
Holding
254
New
9
Increased
49
Reduced
103
Closed
10

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$5.61M
2
AMZN icon
Amazon
AMZN
+$5.48M
3
ORCL icon
Oracle
ORCL
+$3.64M
4
NVDA icon
NVIDIA
NVDA
+$3.45M
5
PWR icon
Quanta Services
PWR
+$3.16M

Top Sells

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$5.58M
2
XOM icon
ExxonMobil
XOM
+$2.98M
3
EMR icon
Emerson Electric
EMR
+$2.87M
4
DHR icon
Danaher
DHR
+$2.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.37M

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Healthcare 18.36%
3 Industrials 12.82%
4 Financials 12.52%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
26
Salesforce
CRM
$158B
$12.6M 1.03%
47,944
+6,740
+16% +$1.53M
PG icon
27
Procter & Gamble
PG
$339B
$12.1M 0.99%
82,746
-1,273
-2% -$189K
J icon
28
Jacobs Solutions
J
$17B
$11.9M 0.97%
110,512
-544
-0.5% -$59.2K
MCD icon
29
McDonald's
MCD
$195B
$11.6M 0.95%
39,214
-20,490
-34% -$5.58M
NSC icon
30
Norfolk Southern
NSC
$75.1B
$11.3M 0.92%
47,720
-410
-0.9% -$85.9K
UNP icon
31
Union Pacific
UNP
$174B
$11.2M 0.92%
45,626
-445
-1% -$97.8K
HON icon
32
Honeywell
HON
$78B
$10.5M 0.86%
53,070
-4,956
-9% -$894K
PEP icon
33
PepsiCo
PEP
$190B
$9.26M 0.76%
54,540
-2,640
-5% -$438K
CVX icon
34
Chevron
CVX
$366B
$9.16M 0.75%
61,402
-3,863
-6% -$584K
AXP icon
35
American Express
AXP
$230B
$8.9M 0.73%
47,497
-702
-1% -$113K
GE icon
36
GE Aerospace
GE
$384B
$8.48M 0.69%
83,236
+60,589
+268% +$5.61M
SHEL icon
37
Shell
SHEL
$245B
$8.43M 0.69%
128,100
+25
+0% +$1.64K
LLY icon
38
Eli Lilly
LLY
$1.06T
$8.42M 0.69%
14,450
+1,420
+11% +$829K
EMR icon
39
Emerson Electric
EMR
$88.3B
$6.92M 0.57%
71,065
-31,347
-31% -$2.87M
ADP icon
40
Automatic Data Processing
ADP
$108B
$6.76M 0.55%
29,001
+145
+0.5% +$33.8K
CVS icon
41
CVS Health
CVS
$122B
$6.6M 0.54%
83,581
-2,923
-3% -$208K
BRK.A icon
42
Berkshire Hathaway Class A
BRK.A
$1.12T
$6.51M 0.53%
12
IBB icon
43
iShares Biotechnology ETF
IBB
$9.71B
$6.47M 0.53%
47,638
-1
-0% -$122
RTX icon
44
RTX Corp
RTX
$301B
$6.35M 0.52%
75,493
-4,964
-6% -$393K
ETN icon
45
Eaton
ETN
$174B
$6.01M 0.49%
24,949
+1,215
+5% +$268K
ABT icon
46
Abbott
ABT
$187B
$5.82M 0.48%
52,870
-1,350
-2% -$135K
LIN icon
47
Linde
LIN
$226B
$5.7M 0.47%
13,882
-25
-0.2% -$9.86K
BMY icon
48
Bristol-Myers Squibb
BMY
$132B
$5.62M 0.46%
109,471
-45,082
-29% -$2.37M
DE icon
49
Deere & Co
DE
$168B
$5.61M 0.46%
14,028
-3,580
-20% -$1.35M
VGT icon
50
Vanguard Information Technology ETF
VGT
$149B
$5.61M 0.46%
92,672
+1,720
+2% +$95.8K

Similar funds

Neville Rodie & Shaw's Q4 2023 Portfolio in Review

As of Q4 2023, Neville Rodie & Shaw held 254 positions worth $1.22B, up 9.1% from $1.12B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Neville Rodie & Shaw's Q4 2023 filing shows 9 new, 49 increased, 103 reduced and 10 closed positions. Its largest new stake was Veralto: 21,059 shares worth $1.73M. The largest sale was McDonald's, an estimated $5.58M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • Neville Rodie & Shaw's largest Q4 2023 buy was Veralto: 21,059 shares worth $1.73M.
  • Neville Rodie & Shaw added most to GE Aerospace in Q4 2023, an estimated $5.61M increase.
  • Neville Rodie & Shaw's biggest Q4 2023 reduction was McDonald's, cutting an estimated $5.58M.
  • Neville Rodie & Shaw fully exited Keysight in Q4 2023, selling an estimated $519K.
  • Neville Rodie & Shaw's ten largest holdings make up 38% of its $1.22B portfolio in Q4 2023.
  • Neville Rodie & Shaw opened 9 new positions and closed 10 in Q4 2023.
  • Neville Rodie & Shaw's portfolio value rose 9.1% quarter-over-quarter to $1.22B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2023, filed 2 Jan 2024.